Overview
For professionals who have moved beyond the basics, advanced GCP Auditing techniques offer the depth required to navigate the complex global regulatory landscape. These techniques are not just about verifying compliance; they are about mastering the science of risk-based auditing, remote auditing, and audit programme management. As a clinical research professional, you are responsible for ensuring that trials are conducted ethically, data is reliable, and participants are protected. This requires advanced skills in auditing across multiple regulatory frameworks including ICH E6(R3), Health Canada Division 5, and FDA requirements.
The Need for Advanced GCP Auditing Techniques
The clinical research industry is moving toward more complex trial designs, including decentralized and hybrid models, and the integration of digital technologies. This shift requires auditors who are not only trained but educated in the principles of risk-based and proportionate approaches. Advanced GCP Auditing techniques help professionals identify potential compliance gaps and implement robust preventive measures. Our courses are designed for those who are ready to lead audit programmes and drive continuous improvement within their organizations.
Detailed Course Breakdown
Course 1: GCP Global Auditor Certification Program
This training program defines the complete knowledge and performance requirements for personnel involved in clinical research to become certified global auditors for Good Clinical Practice (GCP).
Scope: The program integrates GCP requirements from ICH E6(R3), Health Canada Part C, Division 5, and FDA regulations with auditing practices based on ISO 19011:2026 for internal, second-party (vendor/CRO/site audits), and global regulatory compliance auditing.
Description of Modules: The curriculum covers:
- Regulatory Frameworks including ICH E6(R3), Health Canada Division 5, and FDA 21 CFR Parts 50, 56, 312, 314
- Auditing Practices based on ISO 19011:2026 including seven auditing principles
- Audit programme management including objectives, risks, resources, procedures, implementation, monitoring, review, and improvement
- Conducting an audit from initiation, preparation, execution, reporting, to follow-up
- Remote auditing methods including virtual audits, technology considerations, security, and contingency planning
- Competence and evaluation of auditors including personal behaviour, knowledge and skills, evaluation methods, and maintaining competence
Target Audience:
- Quality Assurance Personnel
- Clinical Research Associates (Monitors)
- Study Directors and Clinical Trial Managers
- Clinical Investigators and Site Staff
- Sponsor Personnel
- CRO Personnel
- IRB/IEC Members and Coordinators
- Data Management and Biostatistics Professionals
- Pharmacovigilance and Safety Specialists
- Regulatory Affairs Professionals
- Audit Program Managers
Pricing: $499.00 with group discounts available.
FAQ:
- What is audit programme management? Audit programme management involves setting objectives, identifying risks, allocating resources, establishing procedures, implementing, monitoring, reviewing, and improving the audit programme.
- What are remote auditing methods? Remote auditing methods include virtual audits using technology platforms, with considerations for security, contingency planning, and technology validation.
- What is the role of risk-based approach in auditing? The risk-based approach focuses audit efforts on areas of highest risk to participant safety and data integrity.
- How do you maintain auditor competence? Auditors must maintain competence through ongoing evaluation of personal behaviour, knowledge, skills, and evaluation methods.
- What is second-party auditing? Second-party auditing involves auditing suppliers, vendors, and service providers such as CROs.
Enroll Now: https://www.gxptrainings.com/courses/gcp-global-auditor-certification-program/
Course 2: Good Clinical Practices (ICH E6(R3) Focused)
This comprehensive training program provides an in-depth exploration of the ICH E6(R3) Good Clinical Practice guideline.
Scope: The curriculum is structured to guide participants through the entire guideline, covering the 11 fundamental principles, the expanded roles and responsibilities of sponsors and investigators, rigorous data governance frameworks, and the critical requirements for essential records.
Description of Modules: The curriculum covers:
- ICH E6(R3) overview and its significance in global clinical research
- 11 Fundamental Principles of GCP and their application
- Sponsor responsibilities including oversight and quality management
- Investigator responsibilities including delegation and supervision
- Informed consent requirements and documentation
- Data governance and integrity frameworks
- Essential records and Trial Master File requirements
- Safety reporting and pharmacovigilance obligations
- Risk-based approaches to trial management
- Digital technologies and decentralized trial elements
Target Audience:
- Clinical Investigators and Sub-Investigators
- Sponsor Personnel (Medical, Regulatory, Clinical Operations)
- Clinical Research Associates (Monitors)
- IRB/IEC Members and Coordinators
- Data Management and Biostatistics Professionals
- Quality Assurance and Compliance Staff
Pricing: $149.00 with group discounts available.
FAQ:
- How does ICH E6(R3) support advanced GCP auditing? It provides the regulatory framework that auditors use to assess compliance in clinical trials.
- What is the significance of Annex 1 in ICH E6(R3) for auditors? Annex 1 provides specific guidance on interventional clinical trials, which auditors must understand.
- What are the 11 fundamental principles of GCP? The 11 fundamental principles cover the ethical and scientific foundation of clinical trials, including participant safety, data integrity, and quality management.
- How does ICH E6(R3) address risk-based approaches? It emphasizes proportionate and risk-based approaches to trial management, allowing auditors to focus on areas of highest risk.
- Why is ICH E6(R3) important for auditors? It is the global standard for GCP, and auditors must be familiar with its requirements to assess compliance.
Enroll Now: https://www.gxptrainings.com/courses/ich-e6r3-good-clinical-practices-gcp/
Course 3: Health Canada Good Clinical Practice Training
This comprehensive training program provides clinical research professionals with the knowledge and practical skills required to conduct clinical trials in compliance with Health Canada Food and Drug Regulations (Part C, Division 5) and the ICH E6(R3) GCP guideline.
Scope: The curriculum is aligned with Health Canada’s adoption of ICH E6(R3) effective April 1, 2026.
Description of Modules: The curriculum covers:
- Health Canada regulatory requirements for clinical trials (Part C, Division 5)
- ICH E6(R3) GCP principles and Annex 1
- Sponsor, Qualified Investigator, and REB responsibilities
- Clinical trial application (CTA) and amendment processes
- Informed consent requirements and participant protection
- Safety reporting obligations (AEs, SAEs, SUSARs)
- Data governance and record-keeping requirements
- Quality management and risk-based monitoring
- Investigational product management and GMP compliance
Target Audience:
- Sponsors (commercial and non-commercial/academic)
- Qualified Investigators (QIs) and Principal Investigators
- Research Ethics Board (REB) members and administrators
- Clinical Research Coordinators and study site personnel
- Contract Research Organizations (CROs) and Service Providers
Pricing: Competitive pricing with group discounts available.
FAQ:
- What are the key requirements for Health Canada GCP auditing? Auditors must understand Part C, Division 5 requirements, including REB approval, Qualified Investigator supervision, informed consent, and record retention.
- What is the role of the Qualified Investigator under Health Canada? The Qualified Investigator must be qualified by education, training, and experience, and must supervise the conduct of the clinical trial.
- What is the Clinical Trial Application (CTA) process in Canada? Sponsors must submit a CTA to Health Canada for authorization before initiating a clinical trial.
- What are the safety reporting timelines under Health Canada? Health Canada requires expedited reporting of serious adverse events and suspected unexpected serious adverse reactions within specified timelines.
- What is the role of GMP in clinical trials? Investigational products must be manufactured in compliance with GMP requirements to ensure quality and safety.
Enroll Now: https://www.gxptrainings.com/courses/health-canada-good-clinical-practice-training/
Course 4: HIPAA Clinical Data Privacy, Security & Compliance Training
This training program provides organizations and individuals with a comprehensive understanding of the legal, regulatory, and operational requirements for protecting health information in clinical research and healthcare delivery settings.
Scope: The program covers the full spectrum of privacy, security, and compliance obligations under U.S. federal law and international good practice standards.
Description of Modules: The curriculum covers 10 comprehensive sections:
- HIPAA Overview and regulatory landscape
- HIPAA Privacy Rule requirements and PHI protections
- HIPAA Security Rule requirements and ePHI safeguards
- HIPAA Breach Notification Rule requirements
- GCP and clinical data integrity requirements
- Security controls for information systems and cloud environments
- Regulatory compliance frameworks including FDA, NIST, and ISO
- Incident management and breach response
- Risk assessment methodologies
- Roles and responsibilities of Sponsors, CROs, Investigators, and technology vendors
Target Audience:
- Covered Entities under HIPAA
- Business Associates and their subcontractors
- Clinical Research Professionals
- Security and Compliance Professionals
Pricing: $249.00 with group discounts available.
FAQ:
- Why is HIPAA training important for advanced GCP auditors? Auditors must verify that clinical trials comply with data privacy and security requirements.
- What is the HIPAA Privacy Rule? It establishes national standards to protect individuals’ medical records and other personal health information.
- What is the HIPAA Security Rule? It establishes national standards to protect electronic protected health information.
- What is the HIPAA Breach Notification Rule? It requires covered entities to provide notification following a breach of unsecured protected health information.
- What is the role of NIST in HIPAA compliance? NIST provides frameworks and guidelines for security and privacy controls that support HIPAA compliance.
Enroll Now: https://www.gxptrainings.com/courses/hipaa-clinical-data-privacy-security-compliance-training/
Course 5: Certified Regulatory Affairs Professional (CRAP)
This comprehensive certification program provides regulatory professionals with end-to-end knowledge of the global pharmaceutical regulatory landscape.
Scope: The program covers the complete drug development lifecycle from discovery through post-approval lifecycle management, with specific focus on the regulatory requirements of the FDA, EMA, and PMDA.
Description of Modules: The curriculum covers:
- Global Regulatory Framework overview
- Investigational New Drug (IND) applications
- New Drug Applications (NDA) for innovative pharmaceuticals
- Abbreviated New Drug Applications (ANDA) for generics
- Biologics License Applications (BLA) for biological products
- Orphan Drug Designation for rare disease treatments
- Special Programs including Accelerated Approval and Breakthrough Therapy
- Post-approval lifecycle management
- Regulatory agency interactions and meeting management
- Global regulatory strategy development
Target Audience:
- Regulatory Affairs Professionals
- Pharmaceutical Development and Formulation Scientists
- Quality Assurance/Quality Control Professionals
- Clinical and Nonclinical Development Professionals
- CMC Specialists and Manufacturing Personnel
Pricing: $799.00 with group discounts available.
FAQ:
- How does regulatory affairs training support advanced GCP auditing? Understanding regulatory requirements helps auditors assess compliance with submission requirements.
- What is the difference between an IND and an NDA? An IND authorizes clinical trials, while an NDA requests marketing approval.
- What is the eCTD format and why is it important? eCTD is the standard format for regulatory submissions.
- What is the purpose of an Orphan Drug Designation? It provides incentives for developing drugs for rare diseases.
- What is the role of ICH in global drug development? ICH harmonizes regulatory requirements across regions.
Enroll Now: https://www.gxptrainings.com/courses/certified-regulatory-affairs-professional/
Get Your Team Offer
For organizations looking to enroll multiple participants, we offer specialized team packages and volume discounts. Please reach out to our partnership team to discuss your specific needs and scores.
Contact Us: https://www.gxptrainings.com/contact-us/
Authors
